Strategy

Products and Brands

A diverse portfolio spanning key therapeutic categories, built on quality and innovation.

01

Therapeutic Areas

Avalon Pharma has strengthened its position as an innovative company in the pharmaceutical and healthcare sector, thanks to a diverse portfolio of over 80 brands covering a wide range of therapeutic categories. This enables the company to efficiently and effectively meet diverse medical needs. The portfolio reflects Avalon’s commitment to quality and innovation, offering carefully designed solutions that cater to both consumer and healthcare sector requirements.

Key Therapeutic Categories

Avalon Pharma’s products are designed to meet the needs of key healthcare sectors, and include:

  1. Dermatology

    Topical anti-fungals, wound-healing treatments, hair loss products, acne treatments, topical corticosteroids, skin-lightening products, protective moisturizers, anti-pigmentation products, topical antibacterials, and antiseptics and disinfectants.

  2. Respiratory System

    Medications for cough and common cold, nasal decongestants and anti-infectives, asthma treatments, and systemic antihistamines.

  3. Cardiovascular

    Medications for the treatment of hypertension, and effective therapies for varicose veins and hemorrhoids.

  4. Gastrointestinal and Anti-Infective

    Anti-diabetic medications, dietary supplements, and systemic antibiotics.

  5. Musculoskeletal

    Systemic analgesics and anti-rheumatic anti-inflammatory medications.

  6. Central Nervous System

    Local anesthetics, anticoagulants, and antidepressants.

  7. Genitourinary System

    Anti-fungal and antibacterial treatments for vaginal infections, and effective therapies for erectile dysfunction.

02

Premium Brands

Avalon Pharma takes pride in its leading products that combine effectiveness, safety, and consumer trust:

03

Market Performance and Competitive Position

In 2025, Avalon achieved the highest market performance in its history, rising to 8th place among more than 540 pharmaceutical companies operating in Saudi Arabia, according to official market data. The company also recorded its highest market share ever at 3.1%, reflecting the robustness of its business model, the efficiency of its operational and marketing strategies, and the strength of its product portfolio in target markets.

At the brand level, six of Avalon’s brands ranked first in their respective markets, while another six brands achieved second place in their therapeutic categories. This demonstrates the company’s strong competitive positioning and the high acceptance of its products among healthcare providers and consumers.

On a regional and international level, “Avogain” ranked first in the hair loss treatment market across the Middle East and Africa and was listed among the top ten products globally in this category. This strengthens Avalon Pharma’s regional and international presence and supports its strategic objectives to expand beyond the domestic market, while noting that this performance reflects the reporting period and does not guarantee future results.